Vicapsys Life Sciences, Inc.
OTC:VICP
Overview | Financials
Company Name | Vicapsys Life Sciences, Inc. |
Symbol | VICP |
Currency | USD |
Price | 2 |
Market Cap | 62,377,000 |
Dividend Yield | 0% |
52-week-range | 1 - 3 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Federico Pier |
Website | https://vicapsys.com |
An error occurred while fetching data.
About Vicapsys Life Sciences, Inc.
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD